RAL
Q3 2026 EPS Estimate
$0.63
Aug 10, 2026 · Reports before open
Revenue Estimate
$550M
FY2026E EPS$2.65
FY2027E EPS$3.08

Analyst Sentiment

Wall St. Consensus
Buy
6 analysts·Limited coverage
75
Score
6 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
6100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$45.00
-38.9%
Consensus
$64.50
-12.4%
Bull
$67.00
-9.0%
12-Month Target Range6 analysts
$45.00$64.50$67.00
Current $73.63Consensus
Current Price
$73.63
Above Consensus
$9.13

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+5.74%
EPS+16.20%
FY2028
Rev+6.02%
EPS+17.23%
FY2029
Rev+1.67%
EPS+3.94%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$2.23B$2.36B$2.50B$2.54B
Low$2.21B$2.33B$2.49B$2.51B
High$2.24B$2.40B$2.51B$2.58B
EBITDA Avg$119M$126M$134M$136M
Low$118M$125M$134M$134M
High$120M$128M$134M$138M
EBIT Avg$41M$43M$46M$47M
Low$41M$43M$46M$46M
High$41M$44M$46M$47M
Net Income Avg$298M$348M$408M$425M
Low$290M$323M$360M$418M
High$306M$373M$457M$433M
EPS Avg$2.65$3.08$3.61$3.75
Low$2.56$2.85$3.17$3.68
High$2.70$3.29$4.03$3.82
Analysts (Rev / EPS)8 / 88 / 86 / 35 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$550M$557M$588M$560M$575M$589M$618M$592M
Low$548M$552M$581M$554M$568M$581M$611M$585M
High$552M$565M$597M$569M$583M$598M$628M$602M
EBITDA Avg$29M$30M$31M$30M$31M$32M$33M$32M
Low$29M$30M$31M$30M$30M$31M$33M$31M
High$30M$30M$32M$30M$31M$32M$34M$32M
EBIT Avg$10M$10M$11M$10M$11M$11M$11M$11M
Low$10M$10M$11M$10M$10M$11M$11M$11M
High$10M$10M$11M$10M$11M$11M$12M$11M
Net Income Avg$70M$78M$88M$77M$81M$91M$101M$89M
Low$68M$77M$86M$76M$80M$90M$99M$88M
High$72M$80M$89M$79M$83M$93M$103M$91M
EPS Avg$0.62$0.69$0.78$0.68$0.72$0.81$0.89$0.79
Low$0.60$0.68$0.76$0.67$0.71$0.79$0.88$0.78
High$0.63$0.71$0.79$0.70$0.73$0.82$0.91$0.81
Analysts (Rev / EPS)6 / 76 / 73 / 23 / 53 / 43 / 32 / 42 / 3

Earnings Surprises

Recent Analyst Actions

May 27, 2026Vertical Research
Vertical downgrades Ralliant to Hold on valuation after rally
Target:$65.00
+4.7%from $62.06
May 13, 2026RBC Capital
Ralliant price target raised to $64 from $47 at RBC Capital
Target:$64.00
+7.4%from $59.60
May 13, 2026Oppenheimer
Ralliant price target raised to $65 from $50 at Oppenheimer
Target:$65.00
+9.9%from $59.16
May 13, 2026Barclays
Ralliant price target raised to $67 from $52 at Barclays
Target:$67.00
+13.3%from $59.16
Feb 6, 2026Morgan Stanley
Ralliant price target lowered to $45 from $55 at Morgan Stanley
Target:$45.00
+14.4%from $39.34
Feb 6, 2026Truist Financial
Ralliant price target lowered to $49 from $62 at Truist
Target:$49.00
+27.4%from $38.47
Feb 6, 2026RBC Capital
Ralliant price target lowered to $41 from $52 at RBC Capital
Target:$41.00
+6.4%from $38.54
Feb 6, 2026Oppenheimer
Ralliant price target lowered to $50 from $60 at Oppenheimer
Target:$50.00
+30.2%from $38.39
Feb 6, 2026Vertical Research
Ralliant upgraded to Buy from Hold at Vertical Research
Target:$45.00
+17.2%from $38.39
Dec 15, 2025Oppenheimer
Ralliant price target raised to $60 from $55 at Oppenheimer
Target:$60.00
+18.0%from $50.86
Dec 12, 2025Truist Financial
Ralliant initiated with a Buy at Truist
Target:$62.00
+18.7%from $52.24
Sep 10, 2025Oppenheimer
Ralliant initiated with an Outperform at Oppenheimer
Target:$55.00
+31.1%from $41.95
Sep 2, 2025Morgan Stanley
Ralliant initiated with an Overweight at Morgan Stanley
Target:$55.00
+29.1%from $42.59
Jul 15, 2025Barclays
Ralliant initiated with an Overweight at Barclays
Target:$60.00
+26.7%from $47.36
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.